TD Waterhouse Canada’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.42K Hold
124
– – ﹤0.01% 1838
2026
Q1
$10.9K Buy
+124
New +$11.1K ﹤0.01% 1735
2025
Q2
– Sell
-124
Closed -$9.07K – 2041
2025
Q1
$9.07K Buy
+124
New +$10.2K ﹤0.01% 1426
2023
Q4
– Sell
-179
Closed -$12.1K – 1747
2023
Q3
$12.1K Buy
179
+61
+52% +$3.41K ﹤0.01% 1190
2023
Q2
$8.33K Hold
118
– – ﹤0.01% 1284
2023
Q1
$8.27K Hold
118
– – ﹤0.01% 1263
2022
Q4
$10.8K Buy
118
+39
+49% +$2.65K ﹤0.01% 1201
2022
Q3
$6.55K Hold
79
– – ﹤0.01% 1304
2022
Q2
$5.88K Hold
79
– – ﹤0.01% 1355
2022
Q1
$7.54K Hold
79
– – ﹤0.01% 1386
2021
Q4
$7.58K Buy
+79
New +$5.74K ﹤0.01% 1387

Other funds holding GMED

TD Waterhouse Canada's GMED Position: Q2 2026 in Review

TD Waterhouse Canada held its Globus Medical (GMED) position steady in Q2 2026 at 124 shares worth $9.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

TD Waterhouse Canada first reported a position in GMED in Q4 2021 and has held it in 11 quarters since. The position peaked at $12.1K in Q3 2023. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • TD Waterhouse Canada held 124 shares of Globus Medical worth $9.42K as of Q2 2026.
  • TD Waterhouse Canada left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1838 holding.
  • TD Waterhouse Canada first reported a position in Globus Medical in Q4 2021 and has held it in 11 quarters since.
  • TD Waterhouse Canada's Globus Medical position peaked at $12.1K in Q3 2023.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.